Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus-Reference-Cited by-同舟云学术

Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus

Published:2014-11-27 Issue:4 Volume:85 Page:E116-E122
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Romaguera R.¹,Brugaletta S.²,Gomez-Lara J.¹,Pinar E.³,Jiménez-Quevedo P.⁴,Gracida M.¹,Roura G.¹,Ferreiro J.L.¹,Teruel L.¹,Gómez-Hospital J.A.¹,Montanya E.⁵,Alfonso F.⁶,Valgimigli M.⁷,Sabate M.²,Cequier A.¹

Affiliation:

1. Department of Cardiology, Heart Diseases Institute, Hospital de Bellvitge; IDIBELL, University of Barcelona; Barcelona Spain

2. Department of Cardiology, Thorax Institute; Hospital Clinic, University of Barcelona; Barcelona Spain

3. Department of Cardiology; Hospital Virgen de la Arrixaca; Murcia Spain

4. Department of Cardiology, Cardiovascular Institute; Hospital Clínico San Carlos; Madrid Spain

5. Endocrine Unit, Hospital de Bellvitge; IDIBELL, CIBERDEM, University of Barcelona; Barcelona Spain

6. Department of Cardiology; Hospital la Princesa; Madrid Spain

7. Department of Cardiology, Erasmus MC; Thoraxcenter; Rotterdam the Netherlands

Funder

Spanish Society of Cardiology

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. Beyond restenosis: Five-year clinical outcomes from second-generation coronary stent trials;Cutlip;Circulation,2004

2. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: Pooled volumetric intravascular ultrasound analyses;Sakata;Circ Cardiovasc Interv,2012

3. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome;Reusch;Am J Cardiol,2002

4. Tor of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?;Carter;Catheter Cardiovasc Interv,2004

5. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease;Ferreiro;Diabet Vasc Dis Res,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial;European Heart Journal;2021-11-04

2. Longitudinal Neointimal Distribution Pattern After Everolimus-Eluting Stent Implantation: Insights From Optical Coherence Tomography Study;Cardiovascular Revascularization Medicine;2021-05

3. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design;American Heart Journal;2020-04

4. In Vivo Evaluation of the Synergic Effect of Metformin and mTOR Inhibitors on the Endothelial Healing of Drug-eluting Stents in Diabetic Patients;Revista Española de Cardiología (English Edition);2018-11

5. Evaluación del efecto sinérgico de la metformina y los inhibidores mTOR sobre la endotelización de los stents farmacoactivos en pacientes diabéticos;Revista Española de Cardiología;2018-11